Methylbutyltryptamine
Names
Preferred IUPAC name
N-[2-(1H-Indol-3-yl)ethyl]-N-methylpropan-1-amine
Other names
N-methyl-N-butyltryptamine
Identifiers
  • 848130-12-1 ☒N[EPA]
3D model (JSmol)
ChemSpider
  • InChI=1S/C15H22N2/c1-3-4-10-17(2)11-9-13-12-16-15-8-6-5-7-14(13)15/h5-8,12,16H,3-4,9-11H2,1-2H3 checkY
    Key: PUEYINPKMCBJCA-UHFFFAOYSA-N checkY
  • InChI=1/C15H22N2/c1-3-4-10-17(2)11-9-13-12-16-15-8-6-5-7-14(13)15/h5-8,12,16H,3-4,9-11H2,1-2H3
    Key: PUEYINPKMCBJCA-UHFFFAOYAE
  • CCCCN(C)CCc2c[nH]c1ccccc12
Properties
C15H22N2
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)
Infobox references

MBT, or N-methyl-N-butyltryptamine, is a lesser-known psychedelic drug. MBT was first synthesized by Alexander Shulgin. In his book TiHKAL (Tryptamines I Have Known and Loved), the minimum dosage is listed as 250-400 mg, and the duration listed as 4–6 hours. MBT produces a heavy body load with dehydration, and causes visuals similar to those of DMT. Very little data exists about the pharmacological properties, metabolism, and toxicity of MBT.

MSBT

TiHKAL mentions that a structural isomer of MBT exists, with the butyl group attached at the nitrogen atom. It is known as N-s-butyl-N-methyltryptamine, or MSBT. However, little is known about its psychoactivity.

See also